MKLN1 and hepatocellular carcinoma: Pan et al.39 suggested that MKLN1-AS is highly probable to target miR-22-3p and induce carcinogenic effects, while Xue et al.40 and Wei et al.41 reported that NBAT1 has the potential to hinder the advancement of tumors like renal cell carcinoma and hepatocellular carcinoma.